机译:MiR-223-3P通过直接瞄准CDH6来抑制人骨肉瘤转移和进展
Department of Orthopaedics General Hospital of Chinese People’s Liberation Army;
Department of Medical Molecular Biology Beijing Institute of Biotechnology;
Department of Oncology General Hospital of Chinese People’s Liberation Army;
Department of Traditional Chinese Medicine Xinhua Hospital Affiliated to Shanghai Jiao Tong;
Department of Pathology;
Department of Orthopaedic Surgery Stanford University;
Department of Medical Molecular Biology Beijing Institute of Biotechnology;
Department of Medical Molecular Biology Beijing Institute of Biotechnology;
Department of Oncology General Hospital of Chinese People’s Liberation Army;
Department of Orthopaedic Surgery Stanford University;
Department of Orthopaedics General Hospital of Chinese People’s Liberation Army;
osteosarcoma; miR-223-3p; CDH6; therapy;
机译:MiR-223-3P通过直接瞄准CDH6来抑制人骨肉瘤转移和进展
机译:MicroRNA-128通过直接靶向整合素α2抑制人骨肉瘤细胞的EMT
机译:MiR-223-3P通过靶向Shox2来抑制口腔鳞状细胞癌的增殖和转移
机译:通过整合素靶向聚合物组件抑制癌症转移
机译:miR-223双链体的双链(miR-223-5p和miR-223-3p)抑制癌细胞侵袭性:靶向基因参与膀胱癌的发病机理
机译:miR-223-3p通过直接靶向CDH6抑制人类骨肉瘤转移和进展
机译:通过直接靶向miR-214-3p / dkk3轴以灭活β-catenin核易位和lef1翻译,令人骨菌蛋白抑制骨肉瘤增殖和转移